Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009) [Phase 1]
Phase 1 trial update for Omarigliptin (MK-3102) in participants with impaired renal function has completed with results posted.
-
CLINICAL_TRIALS research · 2015-12-03Clinical Trial Update: Effects of Low Power Laser Therapy on Muscle Performance Isokinetic Pre-exercise in Individuals With Diabetes Mellitus Type II [NA]
A clinical trial evaluating low power laser therapy to improve pre-exercise muscle performance in individuals with Type 2 diabetes mellitus …
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
This clinical trial update reports on continuous glucose monitoring use in subjects with Type 2 Diabetes Mellitus treated with either twice-…
-
CLINICAL_TRIALS research · 2015-12-03Clinical Trial Update: Web-based Support for People With Type 2 Diabetes [NA]
A completed clinical trial evaluating a web-based support program for people with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes [Phase 1]
Phase 1 trial update comparing BioChaperone Combo with Humalog Mix25 and with simultaneous Humalog and Lantus injections in Type 2 diabetes;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: RCT Evaluating Effects of Cosmos Caudatus (Ulam Raja) in T2DM Patients [NA]
A completed randomized controlled trial evaluated Cosmos Caudatus (Ulam Raja) as an intervention for Type 2 Diabetes Mellitus and obesity.
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
This clinical trial update describes a completed study evaluating continuous glucose monitoring paired with ambulatory glucose profiles to c…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence [EARLY_Phase 1]
The EMPATHy Toolkit trial update reports completion of an early-phase 1 study evaluating a behavioral toolkit to help adults with Type 2 dia…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food
A completed clinical trial used continuous glucose monitoring to examine how different foods influence glycemic responses in people with typ…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: The Impact of Food on Blood Sugar in People With Type 2 Diabetes
This clinical trial update summarizes findings on how food intake affects blood sugar in people with Type 2 diabetes. The results may inform…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session. [NA]
This trial result update reports the completed study evaluating the effect of a single hyperbaric oxygen therapy session on insulin resistan…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
A completed clinical trial evaluating endogenous glucose production in adults with Type 2 diabetes mellitus during oral glucose and intraven…
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Study of Circadian Clock Properties in Healthy Subjects, Obese and Type 2 Diabetic Patients.
This clinical trial investigates circadian clock properties in healthy subjects, obese individuals, and patients with type 2 diabetes. The c…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 trial comparing two NN5401 formulations with metformin against biphasic insulin aspart 30 plus metformin in adults with Type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Effects of Tianqi Capsule on Glucose Variability in Patients With Type 2 Diabetes. [NA]
Clinical trial update on the effects of Tianqi Capsule on glucose variability in patients with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative
Results from a completed clinical trial evaluating the effectiveness and cost-effectiveness of the Diabetes Integrated Care Breakthrough Col…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin [Phase 3]
Phase 3 clinical trial comparing two intensification strategies for Type 2 diabetes patients inadequately controlled on basal insulin and me…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition
This clinical trial update defines a therapy matrix for using continuous glucose monitoring in self-monitoring of blood glucose for adults w…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring [NA]
An clinical trial comparing self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM) in Type 2 diabetes has completed…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
A completed observational study evaluating interstitial glucose monitoring using continuous glucose monitoring in patients treated with exen…
-
FDA approval · 2015-11-25FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG KWIKPEN (insulin lispro) submitted by Eli Lilly, resulting in a labeling action for the …
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026) [Phase 3]
A Phase 3 study evaluating the addition of omarigliptin versus sitagliptin in adults with type 2 diabetes inadequately controlled on metform…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: The Drug-drug Interaction of SHR3824 and SP2086 [Phase 1]
A Phase 1 trial update evaluating the drug-drug interaction between SHR3824 and SP2086. The study targets individuals with Type 2 Diabetes.
-
CLINICAL_TRIALS research · 2015-11-25Clinical Trial Update: Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022) [Phase 3]
A Phase 3 trial update evaluating adding omarigliptin (MK-3102) to patients with type 2 diabetes mellitus inadequately controlled on glimepi…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes [NA]
A completed clinical trial evaluating a computer program intended to help primary care providers treat patients with type 2 diabetes.